Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

PublicOTCBB:SNTI
Date1/2000
Raised
Post IPO Valuation

General Information

Offices

Bridgewater, USA
721 Route 202/206
Suite 130
Bridgewater, NJ, 08807
USA

People

President & CEO & Director

Funding

Tags

Senesco Technologies

Senesco Technologies, Inc., a development stage biotechnology company, focuses on the development of technologies to treat programmed cell death diseases in humans. Its technologies are also used to enhance the productivity of fruits, flowers, vegetables, forestry species, and agronomic crops through the control of cell death in plants. The company was founded in 1964 and is headquartered in Bridgewater, New Jersey.

Recent Milestones

Videos

Screenshots

Stock Price

Sources

  1. Senesco Technologies, Inc. Announces Private Placement Financing for Gross Proceeds of $11.5 Million. Funds to be Utilized to Advance Lead Multiple Myeloma Drug Candidate into Phase 1b/2a Clinical Trial (senesco.com) [edit]
  2. Senesco Announces $1.725 Million Equity Financing (bioportfolio.com) [edit]
  3. Senesco Announces up to $25.2 Million Equity Financing (fiercebiotech.com) [edit]
Edit This Page
Last Edited 4/1/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy